Results 41 to 50 of about 2,300 (209)

Paclitaxel: Application in Modern Oncology and Nanomedicine‐Based Cancer Therapy

open access: yesOxidative Medicine and Cellular Longevity, Volume 2021, Issue 1, 2021., 2021
Paclitaxel is a broad‐spectrum anticancer compound, which was derived mainly from a medicinal plant, in particular, from the bark of the yew tree Taxus brevifolia Nutt. It is a representative of a class of diterpene taxanes, which are nowadays used as the most common chemotherapeutic agent against many forms of cancer.
Javad Sharifi-Rad   +24 more
wiley   +1 more source

Multiple sources of contamination in samples from patients reported to have XMRV infection. [PDF]

open access: yesPLoS ONE, 2012
Xenotropic murine leukemia virus (MLV)-related retrovirus (XMRV) was reported to be associated with prostate cancer by Urisman, et al. in 2006 and chronic fatigue syndrome (CFS) by Lombardi, et al. in 2009.
Mary F Kearney   +10 more
doaj   +1 more source

In-depth investigation of archival and prospectively collected samples reveals no evidence for XMRV infection in prostate cancer. [PDF]

open access: yesPLoS ONE, 2012
XMRV, or xenotropic murine leukemia virus (MLV)-related virus, is a novel gammaretrovirus originally identified in studies that analyzed tissue from prostate cancer patients in 2006 and blood from patients with chronic fatigue syndrome (CFS) in 2009 ...
Deanna Lee   +18 more
doaj   +1 more source

No biological evidence of XMRV in blood or prostatic fluid from prostate cancer patients. [PDF]

open access: yesPLoS ONE, 2012
XMRV (xenotropic murine leukemia virus-related virus) was initially discovered in association with prostate cancer and later with chronic fatigue syndrome (CFS).
Ramon Mendoza   +3 more
doaj   +1 more source

XMRV as a Human Pathogen? [PDF]

open access: yesCell Host & Microbe, 2011
Xenotropic murine leukemia virus-related virus (XMRV) has been proposed to be associated with prostate cancer and chronic fatigue syndrome (CFS). This proposition has been controversial because many investigators have failed to replicate the reported associations.
Wainberg, Mark A., Jeang, Kuan-Teh
openaire   +2 more sources

XMRV replicates preferentially in mucosal sites in vivo: Relevance to XMRV transmission? [PDF]

open access: yesRetrovirology, 2011
Xenotropic Murine Leukemia Virus-related Retrovirus (XMRV) was identified from prostate cancer tissue using DNA based ViroChip technology as well as in a cohort of chronic fatigue syndrome patients. To delineate the infection dynamics and dissemination in vivo, we have thus far infected 7 healthy rhesus macaques and 2 pigtailed macaques.
Villinger, Francois   +12 more
openaire   +1 more source

Mechanism for XMRV neurotoxicity [PDF]

open access: yesRetrovirology, 2011
Xenotropic murine leukemia virus-related virus (XMRV) has been found in a high percentage of humans with chronic fatigue syndrome (CFS). However, more recent studies have failed to confirm these results, and it now appears likely that the original findings were due to patient sample contamination. Because it initially appeared that XMRV was involved in
Miller A Dusty   +4 more
openaire   +2 more sources

Antibody responses against xenotropic murine leukemia virus-related virus envelope in a murine model. [PDF]

open access: yesPLoS ONE, 2011
Xenotropic murine leukemia virus-related virus (XMRV) was recently discovered to be the first human gammaretrovirus that is associated with chronic fatigue syndrome and prostate cancer (PC).
Natalia Makarova   +14 more
doaj   +1 more source

No detection of XMRV in blood samples and tissue sections from prostate cancer patients in Northern Europe. [PDF]

open access: yesPLoS ONE, 2011
BACKGROUND: We recently published the rare detection of xenotropic murine leukemia virus-related virus (XMRV) (1/105) in prostate cancer (PCA) tissue of patients in Northern Europe by PCR.
Kristin Stieler   +8 more
doaj   +1 more source

Usikker påvisning av XMRV i pasientprøver [PDF]

open access: diamondTidsskrift for Den norske legeforening, 2011
Trine Haugen
openalex   +2 more sources

Home - About - Disclaimer - Privacy